Your browser doesn't support javascript.
loading
Population Pharmacokinetics and Exposure-Safety Relationships of Alisertib in Children and Adolescents With Advanced Malignancies.
Zhou, Xiaofei; Mould, Diane R; Yuan, Ying; Fox, Elizabeth; Greengard, Emily; Faller, Douglas V; Venkatakrishnan, Karthik.
Afiliación
  • Zhou X; Millennium Pharmaceuticals, Inc, Cambridge, Massachusetts, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
  • Mould DR; Projections Research Inc, Phoenixville, Pennsylvania, USA.
  • Yuan Y; Millennium Pharmaceuticals, Inc, Cambridge, Massachusetts, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
  • Fox E; St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Greengard E; University of Minnesota, Minneapolis, Minnesota, USA.
  • Faller DV; Millennium Pharmaceuticals, Inc, Cambridge, Massachusetts, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
  • Venkatakrishnan K; Millennium Pharmaceuticals, Inc, Cambridge, Massachusetts, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
J Clin Pharmacol ; 62(2): 206-219, 2022 02.
Article en En | MEDLINE | ID: mdl-34435684

Texto completo: 1 Colección: 01-internacional Asunto principal: Pirimidinas / Azepinas / Inhibidores de Proteínas Quinasas / Neoplasias / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: J Clin Pharmacol Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Pirimidinas / Azepinas / Inhibidores de Proteínas Quinasas / Neoplasias / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: J Clin Pharmacol Año: 2022 Tipo del documento: Article